Reinhard Braun
Laser facilitated epicutaneous peptide immunization using dry patch technology
Scheiblhofer S, Drothler S, Braun W, Braun R, Bösch M, Weiss R. Laser facilitated epicutaneous peptide immunization using dry patch technology. Vaccine 2021; 39:5259-5264.
04.08.2021Laser facilitated epicutaneous peptide immunization using dry patch technology
04.08.2021Vaccine 2021; 39:5259-5264
Scheiblhofer Sandra, Drothler Stephan, Braun Werner, Braun Reinhard, Bösch Maximilian, Weiss Richard
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
Bauer M, Brunner P, Bösch M, Braun R, Braun W, Böhler C, Ling V, Pajenda S, Al Jalali V, Matzneller P, Lackner E, Zeitlinger M. Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis. Front Med (Lausanne) 2021; 8:712511.
16.07.2021Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
16.07.2021Front Med (Lausanne) 2021; 8:712511
Bauer Martin, Brunner Patrick M, Bösch Maximilian, Braun Reinhard, Braun Werner, Böhler Christof, Ling Vincent, Pajenda Sahra, Al Jalali Valentin, Matzneller Peter, Lackner Edith, Zeitlinger Markus
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
Scheiblhofer S, Drothler S, Braun W, Braun R, Bösch M, Weiss R. Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding. Vaccine 2021; 39:4399-4403.
26.06.2021Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
26.06.2021Vaccine 2021; 39:4399-4403
Scheiblhofer Sandra, Drothler Stephan, Braun Werner, Braun Reinhard, Bösch Maximilian, Weiss Richard